HC Wainwright maintains BridgeBio Pharma $120 price target
HC Wainwright & Co. maintained a $120.00/share price target for BridgeBio Pharma.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.